Edwards Lifesciences Corp 2024 SR
The report highlights Edwards Lifesciences' 2024 achievements, including treating over 1 million patients with transcatheter technologies and investing over $1 billion in R&D. The company made progress toward its environmental goals, achieving a 17% reduction in Scope 1 and 2 emissions from a 2021 baseline and reaching 39% renewable energy use. Social impact efforts included $19 million in global charitable giving and high employee engagement in philanthropic activities. The report also details the company's commitment to quality, safety, and a culture of belonging, while aligning with GRI, SASB, and TCFD frameworks.
Company: Edwards Lifesciences Corp
Sector: Health Care
Country: United States
Year: 2024
Type: SR
Pages: 61
Edwards Lifesciences Corp
Corporate Impact Report
The report highlights Edwards Lifesciences' 2024 achievements, including treating over 1 million patients with transcatheter technologies and investing over $1 billion in R&D. The company made progress toward its environmental goals, achieving a 17% reduction in Scope 1 and 2 emissions from a 2021 baseline and reaching 39% renewable energy use. Social impact efforts included $19 million in global charitable giving and high employee engagement in philanthropic activities. The report also details the company's commitment to quality, safety, and a culture of belonging, while aligning with GRI, SASB, and TCFD frameworks.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Renewable Energy
Water Consumption
Total Waste
Net Zero Target
Employees